OncoCyte’s newly appointed CEO Ronald Andrews is making good on a promise for more transparency in the company. Investors and analysts witnessed this new level of transparency first hand during a detailed conference call the Alameda, CA-based company held concerning its plan for acquiring Razor Genomics.
OncoCyte Spells Out the Acquisition Plan for Razor Genomics
By Michael Tattory|
2019-09-10T14:45:29-04:00
September 5th, 2019|News|Comments Off on OncoCyte Spells Out the Acquisition Plan for Razor Genomics